Stefano Alivernini

Dr. Stefano Alivernini is an Honorary Professor at the School of Infection & Immunity, University of Glasgow. His research focuses on the role of synovial tissue macrophages, dendritic cells, and microRNAs in rheumatoid arthritis (RA), particularly their contributions to inflammation, remission, and disease flare prediction. He collaborates extensively with institutions like the University of Glasgow, Università di Perugia, and others, contributing to key publications in Immunity, Nature Medicine, and Nature Communications.

Research Interests: Alivernini’s work centers on understanding cellular and molecular mechanisms driving RA pathogenesis. Key areas include synovial tissue macrophage subsets, myeloid cell biology, miRNA regulation (e.g., miR-155, miR-34a), and AI-driven predictive models for flare prevention. His studies highlight how specific cell populations and genetic regulators influence chronic inflammation and treatment resistance.

Publications Trends: His recent work emphasizes translational research, linking basic immunology to clinical applications. For instance, 2024 studies explore AI tools for RA flare prediction and synovial biopsy techniques. Earlier work (2016–2020) established miRNA roles in B-cell and dendritic cell dysregulation, while 2021–2022 papers investigate mitochondrial remodeling and SPP1 pathways in RA and COVID-19 overlap.

Grants & Collaborations: Though specific grants are not listed, his prolific co-authorship network suggests active funding in rheumatology and immunology. He collaborates with Mariola Kurowska-Stolarska, Iain McInnes, and others on projects funded by institutions like the Wellcome Trust or Arthritis Research UK.

Labs/Teams: His work is likely conducted within the University of Glasgow’s rheumatology research groups, focusing on synovial biology and translational immunology.